3 Hot Reads From TheStreet's Top Columnists
Several hot reads.

With Wall Street deep in the red Wednesday and concerns ranging from President Trump's latest China moves to a key Pennsylvania House election, it's a great time to check out Real Moneyour premium site for active investors.

Here are three of Real Money's top columns for Wednesday's session:

Jim Cramer on Tech Stocks

The Nasdaq Composite is bucking the downtrend as of midafternoon and rising even as the Dow and S&P 500 are lower. But TheStreet's founder Jim Cramer writes that "there better be something great happening in the tech world or the whole move up could be erased in a burst of technology-stock selling."

Bonus White Papers: The FAANGs

The FAANGs -- Facebook (FB) , Amazon (AMZN) , Apple (AAPL) , Netflix (NFLX) and Google/Alphabet (GOOG) , (GOOGL) -- have long been the leading names on Wall Street. But do they still have their bite? TheStreet's Real Money and Real Money Pro columnists are taking a closer look at the FAANG stocks, with special bonus white papers on each component name. Click here to check them all out.

Several of the aforementioned tech names are in Jim Cramer's Action Alerts Plus

Apple Should Rally 11% From Here

Our newest bonus white paper comes from columnists Chris Versace and Bob Lang, whose in-depth look at Apple has them giving it a $200 price target (about 11% above current levels). They also note that Apple has risen some 31% over the past year, beating the Nasdaq Composite by three points. To view their authoritative report, click here.

 

More from Investing

Caterpillar Erases Gains Despite Strong Quarterly Results and Raised Forecast

Caterpillar Erases Gains Despite Strong Quarterly Results and Raised Forecast

Spotify Announces Major Upgrade to Free Mobile App

Spotify Announces Major Upgrade to Free Mobile App

Looks like Coca-Cola's M&A Strategy Is Paying Off

Looks like Coca-Cola's M&A Strategy Is Paying Off

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Harley-Davidson CEO: Bold Actions to Boost Performance Coming This Summer

Harley-Davidson CEO: Bold Actions to Boost Performance Coming This Summer